188 related articles for article (PubMed ID: 15878482)
1. Treatment of acute exacerbation of severe-to-very severe COPD with azithromycin in patients vaccinated against Streptococcus pneumoniae.
Cazzola M; Salzillo A; De Giglio C; Piccolo A; Califano C; Noschese P
Respir Med; 2005 Jun; 99(6):663-9. PubMed ID: 15878482
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
[TBL] [Abstract][Full Text] [Related]
3. A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study.
Block SL; Cifaldi M; Gu Y; Paris MM
Clin Ther; 2005 Jun; 27(6):786-94. PubMed ID: 16117986
[TBL] [Abstract][Full Text] [Related]
4. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
Hansen CR; Pressler T; Hoiby N; Johansen HK
J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
[TBL] [Abstract][Full Text] [Related]
5. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.
Lin SH; Kuo PH; Hsueh PR; Yang PC; Kuo SH
Respirology; 2007 Jan; 12(1):81-7. PubMed ID: 17207030
[TBL] [Abstract][Full Text] [Related]
6. Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers.
Pasqua F; Biscione G; Crigna G; Cazzola M
Ther Adv Respir Dis; 2008 Aug; 2(4):209-14. PubMed ID: 19124373
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
Cazzola M; Noschese P; Vinciguerra A; Di Perna F; Califano C; Berra A
Minerva Med; 1998; 89(1-2):15-22. PubMed ID: 9561021
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of clinical effectiveness and direct costs of azithromycin treatment for exacerbation of chronic obstructive pulmonary disease in hospitalized patients and ambulatory care].
Faber M; Jahnz-Rózyk K; Kucharczyk A; Targowski T; From S; Mamełka B
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():96-9. PubMed ID: 15524029
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and tolerance of azithromycin in respiratory tract infections in children].
Toscano MA; Marzullo E; Minneci MS; Salmeri M; Chinnici V; Emanuele A; Gulino A; Malafarina D; Mannino G; Marletta V
Minerva Pediatr; 1995 Jun; 47(6):249-60. PubMed ID: 7476752
[TBL] [Abstract][Full Text] [Related]
11. [The role of macrolides in treatment of exacerbations of chronic obstructive pulmonary disease].
Targowski T; Jahnz-Rózyk K
Pol Merkur Lekarski; 2010 Apr; 28(166):311-4. PubMed ID: 20491344
[TBL] [Abstract][Full Text] [Related]
12. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
Lopez Sisniega J; Profant M; Kostrica R; Waskin H
Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
[TBL] [Abstract][Full Text] [Related]
13. Single-dose azithromycin for the treatment of children with acute otitis media.
Soley CA; Arguedas A
Expert Rev Anti Infect Ther; 2005 Oct; 3(5):707-17. PubMed ID: 16207162
[TBL] [Abstract][Full Text] [Related]
14. What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model.
Canut A; Martín-Herrero JE; Labora A; Maortua H
J Antimicrob Chemother; 2007 Sep; 60(3):605-12. PubMed ID: 17595285
[TBL] [Abstract][Full Text] [Related]
15. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.
Sethi S; Evans N; Grant BJ; Murphy TF
N Engl J Med; 2002 Aug; 347(7):465-71. PubMed ID: 12181400
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial therapy of acute infectious exacerbation of chronic obstructive pulmonary disease.
Chelidze K; Jgarkava M
Georgian Med News; 2008 Jun; (159):27-30. PubMed ID: 18633147
[TBL] [Abstract][Full Text] [Related]
17. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
[TBL] [Abstract][Full Text] [Related]
18. Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis.
Milstone A; Patsimas J; Farzan D; Castaldo R; Singh H; Feurer I; Harnett J; Luke DR;
Clin Ther; 2005 Jun; 27(6):926-39. PubMed ID: 16117993
[TBL] [Abstract][Full Text] [Related]
19. [Bacterial flora in acute exacerbations of chronic obstructive pulmonary disease (COPD) in Kunming, China].
Yang X; Strobel M; Tian L; Barennes H; Buisson Y
Med Mal Infect; 2011 Apr; 41(4):186-91. PubMed ID: 21195565
[TBL] [Abstract][Full Text] [Related]
20. [Study on the relationship between airway bacterial infections and acute exacerbations in patients with chronic obstructive pulmonary disease].
Zhou YQ; Xie CM; Chen DM; Chen L
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 May; 28(5):503-6. PubMed ID: 17877185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
